Corteva, Inc. (NYSE:CTVA) Shares Bought by Adage Capital Partners GP L.L.C.

Adage Capital Partners GP L.L.C. raised its position in Corteva, Inc. (NYSE:CTVA - Free Report) by 17.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 767,137 shares of the company's stock after buying an additional 114,600 shares during the quarter. Adage Capital Partners GP L.L.C. owned about 0.11% of Corteva worth $43,696,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Oak Thistle LLC purchased a new stake in Corteva in the 4th quarter valued at approximately $1,514,000. Van ECK Associates Corp grew its holdings in Corteva by 5.9% during the fourth quarter. Van ECK Associates Corp now owns 9,428,206 shares of the company's stock worth $537,031,000 after acquiring an additional 525,531 shares during the period. Swedbank AB lifted its holdings in Corteva by 51.9% in the fourth quarter. Swedbank AB now owns 695,641 shares of the company's stock valued at $39,624,000 after acquiring an additional 237,764 shares during the period. Assenagon Asset Management S.A. increased its holdings in shares of Corteva by 755.8% in the 4th quarter. Assenagon Asset Management S.A. now owns 552,769 shares of the company's stock valued at $31,486,000 after purchasing an additional 488,181 shares in the last quarter. Finally, S.E.E.D. Planning Group LLC lifted its stake in shares of Corteva by 54.5% in the fourth quarter. S.E.E.D. Planning Group LLC now owns 96,103 shares of the company's stock valued at $5,474,000 after purchasing an additional 33,886 shares during the period. Institutional investors and hedge funds own 81.54% of the company's stock.

Corteva Stock Down 0.8 %

Shares of NYSE:CTVA traded down $0.48 during midday trading on Wednesday, hitting $61.32. 975,720 shares of the company's stock traded hands, compared to its average volume of 3,312,877. The firm's fifty day moving average price is $60.63 and its two-hundred day moving average price is $60.48. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45. Corteva, Inc. has a twelve month low of $50.01 and a twelve month high of $66.24. The company has a market cap of $41.88 billion, a PE ratio of 47.54, a P/E/G ratio of 1.68 and a beta of 0.73.

Corteva (NYSE:CTVA - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. On average, equities research analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Insider Activity

In related news, insider Brian Titus sold 26,560 shares of the business's stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the transaction, the insider now owns 11,347 shares in the company, valued at approximately $723,257.78. The trade was a 70.07 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.14% of the company's stock.

Wall Street Analyst Weigh In

CTVA has been the topic of several research analyst reports. Bank of America boosted their price target on Corteva from $69.00 to $73.00 and gave the stock a "buy" rating in a research note on Tuesday, February 11th. UBS Group lowered their target price on Corteva from $74.00 to $73.00 and set a "buy" rating on the stock in a report on Friday, January 10th. BNP Paribas upgraded shares of Corteva to a "hold" rating in a research report on Monday, February 10th. Oppenheimer raised their target price on shares of Corteva from $70.00 to $72.00 and gave the company an "outperform" rating in a report on Friday, February 7th. Finally, The Goldman Sachs Group started coverage on shares of Corteva in a report on Thursday, March 13th. They issued a "buy" rating and a $71.00 price target on the stock. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $68.13.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.